Authors: THONGPRASERT S

Citation: S. Thongprasert, PHASE-II STUDY OF PACLITAXEL (TAXOL(R)) AND IFOSFAMIDE (HOLOXAN(R)) IN INOPERABLE NON-SMALL-CELL LUNG-CANCER, Lung cancer, 19(3), 1998, pp. 185-189

Authors: CHUA DTT SHAM JST CHOY D LORVIDHAYA V SUMITSAWAN Y THONGPRASERT S VOOTIPRUX V CHEIRSILPA A AZHAR T REKSODIPUTRO AH

Citation: Dtt. Chua et al., PRELIMINARY-REPORT OF THE ASIAN-OCEANIAN CLINICAL ONCOLOGY ASSOCIATION RANDOMIZED TRIAL COMPARING CISPLATIN AND EPIRUBICIN FOLLOWED BY RADIOTHERAPY VERSUS RADIOTHERAPY ALONE IN THE TREATMENT OF PATIENTS WITH LOCOREGIONALLY ADVANCED NASOPHARYNGEAL CARCINOMA, Cancer, 83(11), 1998, pp. 2270-2283

Authors: THONGPRASERT S

Citation: S. Thongprasert, LUNG-CANCER AND QUALITY-OF-LIFE, Australian and New Zealand Journal of Medicine, 28(3), 1998, pp. 397-399

Authors: THONGPRASERT S CHIERSILPA A JAISATHAPORN K CHEWASAKULYONG B ATIKACHAI B SAILAMAI P PROMWAS N

Citation: S. Thongprasert et al., AN OPEN RANDOMIZED STUDY OF GRANISETRON (G) VERSUS GRANISETRON PLUS DEXAMETHASONE (G-INDUCED EMESIS(D) IN THE TREATMENT OF CYTOSTATIC), European journal of cancer, 31A, 1995, pp. 1250-1250

Authors: THONGPRASERT S PHROMWAS N ATIKACHI B JIEMSRIPONG K

Citation: S. Thongprasert et al., PHASE-II STUDY OF 3 DAYS FRACTIONATED DOSAGE OF IFOSFAMIDE, EPIRUBICIN AND CISPLATIN IN SMALL-CELL LUNG-CANCER, Acta oncologica, 33(5), 1994, pp. 573-574

Authors: THONGPRASERT S JIAMSRIPONGES K

Citation: S. Thongprasert et K. Jiamsriponges, IFOSFAMIDE, EPIRUBICIN AND CISPLATIN (IEP) - ANOTHER ACTIVE COMBINATION FOR SMALL-CELL LUNG-CANCER (SCLC), Lung cancer, 10(1-2), 1993, pp. 91-94